Rural Health
Resources by Topic: Prescription drug misuse
Controlled Substance Prescribing Patterns Among Fatal Overdose Decedents with an Opioid, Stimulant, or Both Contributing to Death — Pennsylvania, 2017–2022
Reports on deaths involving opioids without stimulants, deaths involving stimulants without opioids, and deaths involving both opioids and stimulants in Pennsylvania between 2017 and 2022. Includes data for rural and urban areas. Discusses the role of opioid prescribing on overdose deaths.
Author(s): Stephanie Hayden, Stanley M. Murzynski, Ashley Bolton, Carrie Thomas Goetz
Citation: MMWR (Morbidity and Mortality Weekly Report), 74(12), 205-209
Date: 04/2025
Sponsoring organization: Centers for Disease Control and Prevention
view details
Reports on deaths involving opioids without stimulants, deaths involving stimulants without opioids, and deaths involving both opioids and stimulants in Pennsylvania between 2017 and 2022. Includes data for rural and urban areas. Discusses the role of opioid prescribing on overdose deaths.
Author(s): Stephanie Hayden, Stanley M. Murzynski, Ashley Bolton, Carrie Thomas Goetz
Citation: MMWR (Morbidity and Mortality Weekly Report), 74(12), 205-209
Date: 04/2025
Sponsoring organization: Centers for Disease Control and Prevention
view details
The Rural and Urban Supply of Clinicians With a DEA Waiver to Prescribe Buprenorphine in 2022 Prior to the Elimination of the Waiver Requirement
Report explores the differences in rates of clinicians with DEA waivers to prescribe buprenorphine in 2022 in rural versus urban counties. Highlights the rural gaps in access to buprenorphine to treat opioid use disorder prior to the elimination of the DEA waiver requirement in 2023. Provides rural, urban, and regional comparisons.
Date: 04/2025
Sponsoring organization: WWAMI Rural Health Research Center
view details
Report explores the differences in rates of clinicians with DEA waivers to prescribe buprenorphine in 2022 in rural versus urban counties. Highlights the rural gaps in access to buprenorphine to treat opioid use disorder prior to the elimination of the DEA waiver requirement in 2023. Provides rural, urban, and regional comparisons.
Date: 04/2025
Sponsoring organization: WWAMI Rural Health Research Center
view details
Synthetic Opioid and Stimulant Co-Involved Overdose Deaths by Occupation and Industry — United States, 2022
Examines occupations and industries with higher percentages of psychostimulant involvement in synthetic opioid overdose deaths. Includes information on occupations such as mining and farming, fishing, and forestry that are more common in rural areas.
Author(s): Eric W. Lundstrom, Alexandria Macmadu, Andrea L. Steege, Matthew Groenewold
Citation: MMWR (Morbidity and Mortality Weekly Report), 74(10), 173–178
Date: 03/2025
Sponsoring organization: Centers for Disease Control and Prevention
view details
Examines occupations and industries with higher percentages of psychostimulant involvement in synthetic opioid overdose deaths. Includes information on occupations such as mining and farming, fishing, and forestry that are more common in rural areas.
Author(s): Eric W. Lundstrom, Alexandria Macmadu, Andrea L. Steege, Matthew Groenewold
Citation: MMWR (Morbidity and Mortality Weekly Report), 74(10), 173–178
Date: 03/2025
Sponsoring organization: Centers for Disease Control and Prevention
view details
Opioid Use Among Rural Medicare Beneficiaries
Examines trends in prescription opioid use among Medicare beneficiaries in rural areas, utilizing 2010-2017 Medicare Current Beneficiary Survey (MCBS) data. Provides data on receipt of opioid prescriptions among community-dwelling and facility-dwelling beneficiaries, associations between prescribing and chronic overlapping pain conditions (COPCs), and prescriptions exceeding CDC guidelines. Includes rural-urban comparisons.
Author(s): Yvonne Jonk, Heidi O'Connor, Karen Pearson, et al.
Date: 01/2025
Sponsoring organization: Maine Rural Health Research Center
view details
Examines trends in prescription opioid use among Medicare beneficiaries in rural areas, utilizing 2010-2017 Medicare Current Beneficiary Survey (MCBS) data. Provides data on receipt of opioid prescriptions among community-dwelling and facility-dwelling beneficiaries, associations between prescribing and chronic overlapping pain conditions (COPCs), and prescriptions exceeding CDC guidelines. Includes rural-urban comparisons.
Author(s): Yvonne Jonk, Heidi O'Connor, Karen Pearson, et al.
Date: 01/2025
Sponsoring organization: Maine Rural Health Research Center
view details
Community Opioid Overdose Reversal Medications (OORMs) Planning Toolkit
Provides planning and strategy resources for organizations and communities to expand access to naloxone and other opioid overdose reversal medications (OORMs). Includes templates, implementation strategies and program examples, and more. Discusses rural considerations and programs throughout, including the Rural EMS Training Program and Rural Communities Opioid Response Program (RCORP).
Date: 01/2025
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
Provides planning and strategy resources for organizations and communities to expand access to naloxone and other opioid overdose reversal medications (OORMs). Includes templates, implementation strategies and program examples, and more. Discusses rural considerations and programs throughout, including the Rural EMS Training Program and Rural Communities Opioid Response Program (RCORP).
Date: 01/2025
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
A Rural-Urban Analysis of Buprenorphine Therapy During and After Pregnancy Among the Commercially Insured
Explores the use of evidence-based buprenorphine treatment and adherence during the peri-pregnancy period among commercially insured individuals by rurality. Analyzes data on 1,331,040 people between 15 and 44 years-old with diagnosis codes for pregnancy and labor/delivery from January 1, 2015, to December 31, 2019.
Author(s): KariLynn Dowling-McClay, Bill Brooks, Daniel Krauss, et al.
Date: 01/2025
Sponsoring organization: ETSU/NORC Rural Health Research Center
view details
Explores the use of evidence-based buprenorphine treatment and adherence during the peri-pregnancy period among commercially insured individuals by rurality. Analyzes data on 1,331,040 people between 15 and 44 years-old with diagnosis codes for pregnancy and labor/delivery from January 1, 2015, to December 31, 2019.
Author(s): KariLynn Dowling-McClay, Bill Brooks, Daniel Krauss, et al.
Date: 01/2025
Sponsoring organization: ETSU/NORC Rural Health Research Center
view details
Patient Centered Medication Treatment for Opioid Use Disorder in Rural Vermont: A Qualitative Study
Examines patient perspectives on medications for opioid use disorder (MOUD) treatment in rural Vermont, utilizing interview data from 15 people who received care at Vermont Hub and Spoke clinics. Highlights patient perspectives on aspects of patient-centered care, and their influences on retention and engagement with treatment.
Author(s): Emily G. Hichborn, Owen B. Murray, Eilis I. Murphy, et al.
Citation: Addiction Science & Clinical Practice, 20, 3
Date: 01/2025
view details
Examines patient perspectives on medications for opioid use disorder (MOUD) treatment in rural Vermont, utilizing interview data from 15 people who received care at Vermont Hub and Spoke clinics. Highlights patient perspectives on aspects of patient-centered care, and their influences on retention and engagement with treatment.
Author(s): Emily G. Hichborn, Owen B. Murray, Eilis I. Murphy, et al.
Citation: Addiction Science & Clinical Practice, 20, 3
Date: 01/2025
view details
Implementation of Mobile Medication Units: Findings from a Qualitative Study
Provides a brief overview of the development of policy regarding the approval of mobile medication units (MMUs) operated by opioid treatment programs (OTPs). Presents findings from an environmental scan and key informant interviews regarding MMU implementation. Discusses barriers to establishing, sustaining, and expanding MMU services. Describes opportunities to increase access to methadone in underserved communities. Includes rural references throughout.
Date: 01/2025
Sponsoring organizations: HHS Office of the Assistant Secretary for Planning and Evaluation, Mathematica
view details
Provides a brief overview of the development of policy regarding the approval of mobile medication units (MMUs) operated by opioid treatment programs (OTPs). Presents findings from an environmental scan and key informant interviews regarding MMU implementation. Discusses barriers to establishing, sustaining, and expanding MMU services. Describes opportunities to increase access to methadone in underserved communities. Includes rural references throughout.
Date: 01/2025
Sponsoring organizations: HHS Office of the Assistant Secretary for Planning and Evaluation, Mathematica
view details
Expanding the Opioid Use Disorder Medication Treatment Workforce in Rural Communities Through the RCORP Initiative
Examines the impact of the Rural Communities Opioid Response Program (RCORP) on the workforce supply of Drug Enforcement Administration (DEA)-waivered clinicians in rural areas, who are able to prescribe buprenorphine. Analyzes 2017–2022 DEA lists of waivered clinicians to report on counties with a waivered clinician, clinician-to-population ratios, and treatment slot-to-population ratios. Discusses the impact of RCORP funding on Opioid Use Disorder (OUD) recovery services in rural communities.
Author(s): C. Holly A. Andrilla, Sara C. Woolcock, Kathleen Meyers, Davis G. Patterson
Citation: Journal of Rural Health, 41(1), e12867
Date: 2025
view details
Examines the impact of the Rural Communities Opioid Response Program (RCORP) on the workforce supply of Drug Enforcement Administration (DEA)-waivered clinicians in rural areas, who are able to prescribe buprenorphine. Analyzes 2017–2022 DEA lists of waivered clinicians to report on counties with a waivered clinician, clinician-to-population ratios, and treatment slot-to-population ratios. Discusses the impact of RCORP funding on Opioid Use Disorder (OUD) recovery services in rural communities.
Author(s): C. Holly A. Andrilla, Sara C. Woolcock, Kathleen Meyers, Davis G. Patterson
Citation: Journal of Rural Health, 41(1), e12867
Date: 2025
view details
Substance Use Prevalence Among Indiana Youth
Provides 2024 information on substance use among youth in Indiana, with data on 30-day use rates, highest use substances, monthly use of electronic vapor products and other substances, and prevalence rates of rural student substance use.
Date: 12/2024
Sponsoring organization: Indiana Youth Institute
view details
Provides 2024 information on substance use among youth in Indiana, with data on 30-day use rates, highest use substances, monthly use of electronic vapor products and other substances, and prevalence rates of rural student substance use.
Date: 12/2024
Sponsoring organization: Indiana Youth Institute
view details